Your browser doesn't support javascript.
loading
Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack.
Johnston, S Claiborne; Amarenco, Pierre; Aunes, Maria; Denison, Hans; Evans, Scott R; Himmelmann, Anders; Jahreskog, Marianne; James, Stefan; Knutsson, Mikael; Ladenvall, Per; Molina, Carlos A; Nylander, Sven; Röther, Joachim; Wang, Yongjun.
Afiliação
  • Johnston SC; Dean's Office, Dell Medical School, University of Texas at Austin (S.C.J.).
  • Amarenco P; Department of Neurology and Stroke Center, Bichat Hospital, Paris University, France (P.A.).
  • Aunes M; AstraZeneca, Biopharmaceuticals R&D, Gothenburg, Sweden (M.A., H.D., A.H., M.J., M.K., P.L., S.N.).
  • Denison H; AstraZeneca, Biopharmaceuticals R&D, Gothenburg, Sweden (M.A., H.D., A.H., M.J., M.K., P.L., S.N.).
  • Evans SR; Biostatistics Center, George Washington University (S.R.E.).
  • Himmelmann A; AstraZeneca, Biopharmaceuticals R&D, Gothenburg, Sweden (M.A., H.D., A.H., M.J., M.K., P.L., S.N.).
  • Jahreskog M; AstraZeneca, Biopharmaceuticals R&D, Gothenburg, Sweden (M.A., H.D., A.H., M.J., M.K., P.L., S.N.).
  • James S; Department of Medical Sciences, Uppsala University, Sweden (S.J.).
  • Knutsson M; AstraZeneca, Biopharmaceuticals R&D, Gothenburg, Sweden (M.A., H.D., A.H., M.J., M.K., P.L., S.N.).
  • Ladenvall P; AstraZeneca, Biopharmaceuticals R&D, Gothenburg, Sweden (M.A., H.D., A.H., M.J., M.K., P.L., S.N.).
  • Molina CA; Stroke Unit, Hospital Vall d'Hebron, Barcelona, Spain (C.A.M.).
  • Nylander S; AstraZeneca, Biopharmaceuticals R&D, Gothenburg, Sweden (M.A., H.D., A.H., M.J., M.K., P.L., S.N.).
  • Röther J; Department of Neurology, Asklepios Klinik Altona, Hamburg, Germany (J.R.).
  • Wang Y; Department of Neurology, Tiantan Hospital, Capital Medical University, Beijing, China (Y.W.).
Stroke ; 52(11): 3482-3489, 2021 11.
Article em En | MEDLINE | ID: mdl-34477459

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores da Agregação Plaquetária / Hemorragia Cerebral / Aspirina / Ticagrelor / AVC Isquêmico Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores da Agregação Plaquetária / Hemorragia Cerebral / Aspirina / Ticagrelor / AVC Isquêmico Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article